390.73MMarket Cap
LossP/E TTM
Cybin Inc's Company Valuation
Currency: USD Updated: 2026-01-02The current valuation score of Cybin Inc is 7.33, ranking 142 out of 403 in the Biotechnology & Medical Research industry. Its current P/E ratio is -2.11, which is -39.13% below the recent high of -1.29 and -6307.27% above the recent low of -135.26.

Relevant data have not been disclosed by the company yet.

Relevant data have not been disclosed by the company yet.

Relevant data have not been disclosed by the company yet.

Relevant data have not been disclosed by the company yet.